DK1440067T3 - N-formyl-derivater af paroxetin - Google Patents
N-formyl-derivater af paroxetinInfo
- Publication number
- DK1440067T3 DK1440067T3 DK02768169T DK02768169T DK1440067T3 DK 1440067 T3 DK1440067 T3 DK 1440067T3 DK 02768169 T DK02768169 T DK 02768169T DK 02768169 T DK02768169 T DK 02768169T DK 1440067 T3 DK1440067 T3 DK 1440067T3
- Authority
- DK
- Denmark
- Prior art keywords
- paroxetine
- formyl derivatives
- formyl
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33043001P | 2001-10-22 | 2001-10-22 | |
| PCT/NL2002/000654 WO2003044012A1 (en) | 2001-10-22 | 2002-10-15 | N-formyl derivatives of paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1440067T3 true DK1440067T3 (da) | 2005-04-11 |
Family
ID=23289741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02768169T DK1440067T3 (da) | 2001-10-22 | 2002-10-15 | N-formyl-derivater af paroxetin |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US6703408B2 (da) |
| EP (1) | EP1440067B1 (da) |
| AR (1) | AR036860A1 (da) |
| AT (1) | ATE285408T1 (da) |
| AU (1) | AU2002330771A1 (da) |
| CA (1) | CA2464327A1 (da) |
| DE (2) | DE20220955U1 (da) |
| DK (1) | DK1440067T3 (da) |
| ES (1) | ES2230516T3 (da) |
| HU (1) | HUP0401895A2 (da) |
| IL (1) | IL161521A0 (da) |
| NO (1) | NO20042101L (da) |
| NZ (1) | NZ532432A (da) |
| PT (1) | PT1440067E (da) |
| WO (1) | WO2003044012A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6777554B2 (en) | 2001-02-05 | 2004-08-17 | Teva Pharmaceutical Industries Ltd. | Preparation of N-methylparoxetine and related intermediate compounds |
| WO2006018318A1 (en) * | 2004-08-18 | 2006-02-23 | Synthon B.V. | Liquid paroxetine compositions |
| CA2629514A1 (en) * | 2005-11-14 | 2007-05-24 | Auspex Pharmaceuticals, Inc. | Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| US9138430B2 (en) * | 2007-12-27 | 2015-09-22 | Mylan Specialty L.P. | Formulation and method for the release of paroxetine in the large intestine |
| CN109507349A (zh) * | 2017-09-15 | 2019-03-22 | 万全万特制药江苏有限公司 | 液相色谱法分离测定帕罗西汀中间体光学异构体的方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
| US5856493A (en) * | 1995-02-06 | 1999-01-05 | Smithkline Beecham Corporation | Process for making novel form of paroxeting hydrochloride anhydrate |
| JP3446468B2 (ja) | 1996-04-15 | 2003-09-16 | 旭硝子株式会社 | ピペリジンカルビノール類の製造方法 |
| EP0812829A1 (en) | 1996-06-14 | 1997-12-17 | Ontogen Corporation | Substituted imidazoles as modulators of multi-drug resistance |
| ATE279393T1 (de) | 1997-05-29 | 2004-10-15 | Smithkline Beecham Corp | Neues verfahren |
| GB9810181D0 (en) * | 1998-05-13 | 1998-07-08 | Smithkline Beecham Plc | Novel formulations |
| CZ20011465A3 (cs) | 1998-11-02 | 2001-08-15 | Synthon B. V. | Způsob přípravy 4-arylpiperidin-3-methanolů a příbuzných sloučenin |
| US6239126B1 (en) * | 1998-12-17 | 2001-05-29 | American Home Products Corporation | Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives |
| GB9916392D0 (en) | 1999-07-13 | 1999-09-15 | Smithkline Beecham Plc | Novel process |
| IT1313702B1 (it) | 1999-08-02 | 2002-09-09 | Chemi Spa | Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine. |
| JP2004507504A (ja) * | 2000-08-28 | 2004-03-11 | シントン・ベスローテン・フェンノートシャップ | パロキセチン組成物およびその製造方法 |
| US6755653B2 (en) * | 2001-10-25 | 2004-06-29 | Cubic Defense Systems, Inc. | System and method for preventing cheating in a simulated combat exercise |
-
2002
- 2002-10-15 AT AT02768169T patent/ATE285408T1/de not_active IP Right Cessation
- 2002-10-15 NZ NZ532432A patent/NZ532432A/en unknown
- 2002-10-15 AU AU2002330771A patent/AU2002330771A1/en not_active Abandoned
- 2002-10-15 EP EP02768169A patent/EP1440067B1/en not_active Expired - Lifetime
- 2002-10-15 PT PT02768169T patent/PT1440067E/pt unknown
- 2002-10-15 DE DE20220955U patent/DE20220955U1/de not_active Expired - Lifetime
- 2002-10-15 CA CA002464327A patent/CA2464327A1/en not_active Abandoned
- 2002-10-15 DK DK02768169T patent/DK1440067T3/da active
- 2002-10-15 HU HU0401895A patent/HUP0401895A2/hu unknown
- 2002-10-15 IL IL16152102A patent/IL161521A0/xx unknown
- 2002-10-15 DE DE60202381T patent/DE60202381T2/de not_active Expired - Fee Related
- 2002-10-15 WO PCT/NL2002/000654 patent/WO2003044012A1/en not_active Application Discontinuation
- 2002-10-15 ES ES02768169T patent/ES2230516T3/es not_active Expired - Lifetime
- 2002-10-21 AR ARP020103949A patent/AR036860A1/es not_active Application Discontinuation
- 2002-10-21 US US10/274,051 patent/US6703408B2/en not_active Expired - Fee Related
-
2004
- 2004-01-20 US US10/759,437 patent/US20040147497A1/en not_active Abandoned
- 2004-01-20 US US10/759,436 patent/US20040266825A1/en not_active Abandoned
- 2004-05-21 NO NO20042101A patent/NO20042101L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE20220955U1 (de) | 2004-09-02 |
| US20040147497A1 (en) | 2004-07-29 |
| US20030125560A1 (en) | 2003-07-03 |
| AU2002330771A1 (en) | 2003-06-10 |
| NO20042101L (no) | 2004-05-21 |
| WO2003044012A1 (en) | 2003-05-30 |
| AR036860A1 (es) | 2004-10-06 |
| NZ532432A (en) | 2005-02-25 |
| US6703408B2 (en) | 2004-03-09 |
| US20040266825A1 (en) | 2004-12-30 |
| EP1440067A1 (en) | 2004-07-28 |
| IL161521A0 (en) | 2004-09-27 |
| ATE285408T1 (de) | 2005-01-15 |
| CA2464327A1 (en) | 2003-05-30 |
| HUP0401895A2 (hu) | 2004-12-28 |
| EP1440067B1 (en) | 2004-12-22 |
| ES2230516T3 (es) | 2005-05-01 |
| PT1440067E (pt) | 2005-02-28 |
| DE60202381D1 (de) | 2005-01-27 |
| DE60202381T2 (de) | 2005-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1438306T3 (da) | Derivater af UK-2A | |
| DK1360169T3 (da) | Succinatsalt af O-desmethyl-venlafaxin | |
| ATE370137T1 (de) | 4-(6-gliedriger)-heteroaryl-acyl-pyrrolidin derivate als hcv-inhibitoren | |
| DK1515969T3 (da) | Spiroindolinpiperidinderivater | |
| AR028567A1 (es) | Nuevos derivados de fenil-propargileter | |
| DE60233399D1 (de) | Erzerrung zweiter ordnung | |
| ATE319451T1 (de) | Tetrahydrochinolin-derivate | |
| ATE312827T1 (de) | 3-substituierte-4-pyrimidonderivate | |
| ATE438644T1 (de) | Chinazolinderivate | |
| AR028596A1 (es) | Nuevos derivados de fenilglicina | |
| NO20033203D0 (no) | Terapeutiske heterocykliske forbindelser | |
| DK1476162T3 (da) | Kontrolleret syntese af ziprasidone | |
| NO20034970D0 (no) | Nye arylheteroalkylaminderivater | |
| ATE308543T1 (de) | Piperidinderivate | |
| DK1178986T3 (da) | Furanonderivater som inhibitorer af cathepsin S | |
| EE200300447A (et) | Asendatud bensofuraan-2-karboksamiidide derivaadid | |
| ATE335729T1 (de) | 3h-chinazoline -4-on derivaten | |
| IS8109A (is) | Nýjar 3-dekladínósýl 9a-N-karbamóýl og 9a-N-þíókarbamóýl afleiður af 9-deoxó-9-díhýdró-9a-asa-9a-hómóerýþrómýsíni A | |
| ATE423771T1 (de) | Tetrahydrochinolinderivate | |
| DE60223031D1 (de) | Arylpiperazin gebundene tetrahydroindolonderivate | |
| PT1322592E (pt) | Derivados substituidos de 1-aminobutan-3-ol | |
| DE60210058D1 (de) | Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten | |
| DK1440067T3 (da) | N-formyl-derivater af paroxetin | |
| NO20035248D0 (no) | Nye fenylalkyloksy-fenyl derivater | |
| DE60200407D1 (de) | Methylendioxy- Derivate |